Unbiased Analysis of Today's Healthcare Issues

Early Alzheimer’s Diagnosis could save U.S. $7.9 billion

That is the conclusion from a Bloomberg article highlighting some research done by some of my colleagues at Precision Health Economics in conjunction with the Alzheimer’s Association.  An excerpt is below. The Alzheimer’s Association commissioned researchers at Precision Health Economics to study the potential savings of obtaining an earlier diagnosis. It used data from the Health […]

Read the rest of this entry »

After 190 failed tries…

Why are pharmaceuticals so expensive?  One reasons is that there is a lot of research that goes into developing a drug.  Most of that research results in drugs that don’t work.  One example is the search for Alzheimer’s treatment.  As Bloomberg reports: Drug companies have long focused on a different protein called amyloid that clumps in […]

Read the rest of this entry »

Alzheimer’s Awareness Month

This month is Alzheimer’s awareness month. To draw attention to the burden of irreversible, progressive brain disorder, today the Healthcare Economist is providing some facts about the disease, courtesy of the CDC, the Mayo Clinic, NIH Alzheimer’s disease is a progressive disease that destroys memory and other important mental functions. It’s the most common cause of dementia — a […]

Read the rest of this entry »